ESR1 and breast cancer: By comparing the highest prioritized cell line BT-483 with the commonly used cell line MCF-7 for breast cancer, we found both cell lines showed a high estrogen signaling activity (Fig. 7a), which is in line with the report that both cell lines are estrogen receptor (ER)-positive29.